GlaxoSmithKline, one of the world’s largest drug developers, is “currently working on integrating (ResearchKit) into clinical trials and planning to start in coming months,” Buzzfeed reports. GSK didn’t provide specifics on its plans, but Michelle Crouthamel, a project manager with the company’s Digital Platform Performance unit, said ResearchKit offers a chance “to improve patient engagement and data collection.” Purdue…
